Tanvex BioPharma Market Cap

Tanvex BioPharma has a market cap or net worth of 10.65 billion as of April 28, 2026. Its market cap has decreased by -29.03% in one year.

Market Cap

10.65B

Enterprise Value

11.35B

Revenue

400.97M

Ranking

n/a

PE Ratio

n/a

Stock Price

39.75

Market Cap Chart

Since August 13, 2015, Tanvex BioPharma's market cap has decreased from 16.77B to 10.65B, a decrease of -36.51%. That is a compound annual growth rate of -4.15%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	10.65B	-26.90%
Dec 31, 2025	14.56B	36.15%
Dec 31, 2024	10.70B	22.75%
Dec 29, 2023	8.71B	-29.59%
Dec 30, 2022	12.38B	-39.56%
Dec 30, 2021	20.48B	106.96%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CHO Pharma	11.39B
Ever Supreme Bio Technology	11.43B
Gongwin Biopharm Holdings	8.73B
Locus Cell	13.12B
TaiMed Biologics	13.20B
EirGenix	13.95B
PharmaEngine	7.73B
Adimmune	7.65B

Market Cap Rankings